by TractManager | Sep 28, 2011 | Emerging Technology Report
An oral protease inhibitor for the treatment of hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.If you have a...
by TractManager | Sep 26, 2011 | Emerging Technology Report
An oral anticoagulant for prevention of venous thromboembolism (VTE) following major orthopedic surgery.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Sep 23, 2011 | Emerging Technology Report
A twice-yearly, injected, antiresorptive biologic agent that is being developed for the prevention and treatment of bone loss due to hormone ablation therapies for breast or prostate cancer.If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | Sep 7, 2011 | Emerging Technology Report
An implantable pulse generator being developed as an occipital nerve stimulator for the management of medically refractory chronic migraine headache.If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments